{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T23:09:18Z","timestamp":1777936158822,"version":"3.51.4"},"reference-count":15,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,5,1]]},"DOI":"10.2169\/internalmedicine.5165-24","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:07:50Z","timestamp":1757542070000},"page":"1268-1272","source":"Crossref","is-referenced-by-count":0,"title":["Treatment with Daratumumab for Immunotactoid Glomerulopathy Associated with Plasma Cell Dyscrasia: A Report of Two Cases"],"prefix":"10.2169","volume":"65","author":[{"given":"Atsushi","family":"Uehara","sequence":"first","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, Kameda Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuaki","family":"Oura","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, Kameda Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, Kameda Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rikako","family":"Tabata","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, Kameda Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Narita","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, Kameda Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, Kameda Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomo","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kameda Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Analytic Human Pathology, Nippon Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosei","family":"Matsue","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, Kameda Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Schwartz MM, Korbet SM, Lewis EJ. Immunotactoid glomerulopathy. J Am Soc Nephrol 13: 1390-1397, 2002.","DOI":"10.1097\/01.ASN.0000013397.06964.19"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Fogo AB, Lusco MA, Najafian B, Alpers CE. AJKD atlas of renal pathology: immunotactoid glomerulopathy. Am J Kidney Dis 66: e29-e30, 2015.","DOI":"10.1053\/j.ajkd.2015.08.003"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Nasr SH, Kudose SS, Said SM, et al. Immunotactoid glomerulopathy is a rare entity with monoclonal and polyclonal variants. Kidney Int 99: 410-420, 2021.","DOI":"10.1016\/j.kint.2020.07.037"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hogan JJ, Vogl DT. Untangling immunotactoid glomerulopathy in the MGRS era. Kidney Int 99: 303-305, 2021.","DOI":"10.1016\/j.kint.2020.09.013"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Javaugue V, Dufour-Nourigat L, Desport E, et al. Results of a nation-wide cohort study suggest favorable long-term outcomes of clone-targeted chemotherapy in immunotactoid glomerulopathy. Kidney Int 99: 421-430, 2021.","DOI":"10.1016\/j.kint.2020.06.039"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Karanfilovski V, Ristovska V, Gjorgjievski N, Nikolov IG, Dzekova-Vidimliski P, Petrushevska G. Immunotactoid glomerulopathy: a rare glomerular disease case study. Indian J Nephrol 33: 140-143, 2023.","DOI":"10.4103\/ijn.ijn_107_22"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Schwartz MM, Lewis EJ. The quarterly case: nephrotic syndrome in a middle-aged man. Ultrastruct Pathol 1: 575-582, 1980.","DOI":"10.3109\/01913128009140563"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Bridoux F, Hugue V, Coldefy O, et al. Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features. Kidney Int 62: 1764-1775, 2002.","DOI":"10.1046\/j.1523-1755.2002.00628.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ohashi A, Kumagai J, Nagahama K, Fujisawa H. Case of immunotactoid glomerulopathy showing high responsiveness to steroids therapy despite severe pathological features. BMJ Case Rep 12: 2019.","DOI":"10.1136\/bcr-2019-229751"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Sugita E, Sonoda H, Ryuzaki M, et al. Diagnosis of monoclonal immunotactoid glomerulopathy with positive \u03bb chain by immunoelectron microscopy. CEN Case Rep 12: 7-13, 2023.","DOI":"10.1007\/s13730-022-00714-1"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Inotani S, Horino T, Ishihara M, Ichii O, Matsumori A. Immunotactoid glomerulopathy associated with monoclonal gammopathy. Lancet 397: 2081, 2021.","DOI":"10.1016\/S0140-6736(21)00477-3"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Khandelwal A, Trinkaus MA, Ghaffar H, Jothy S, Goldstein MB. A case report of unusually long lag time between immunotactoid glomerulopathy (itg) diagnosis and diffuse large B-cell lymphoma (DLBCL) development. BMC Nephrol 17: 140, 2016.","DOI":"10.1186\/s12882-016-0349-9"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Leflot S, Leroy P, Demoulin N, et al. Crystalglobulin-associated kidney disease: a case report and literature review. Kidney Med 4: 100445, 2022.","DOI":"10.1016\/j.xkme.2022.100445"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Dimopoulos MA, Merlini G, Bridoux F, et al.; the International Myeloma Working Group. Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group. Lancet Oncol 24: e293-e311, 2023.","DOI":"10.1016\/S1470-2045(23)00223-1"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kuzume A, Tabata R, Terao T, et al. Safety and efficacy of daratumumab in patients with multiple myeloma and severe renal failure. Br J Haematol 193: e33-e36, 2021.","DOI":"10.1111\/bjh.17412"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/9\/65_5165-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:21:26Z","timestamp":1777692086000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/9\/65_5165-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5165-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"article-number":"5165-24"}}